208 related articles for article (PubMed ID: 21733326)
1. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
Gómez-Zorita S; Fernández-Quintela A; Macarulla MT; Aguirre L; Hijona E; Bujanda L; Milagro F; Martínez JA; Portillo MP
Br J Nutr; 2012 Jan; 107(2):202-10. PubMed ID: 21733326
[TBL] [Abstract][Full Text] [Related]
2. Protective role of Vitamin E pre-treatment on N-nitrosodiethylamine induced oxidative stress in rat liver.
Bansal AK; Bansal M; Soni G; Bhatnagar D
Chem Biol Interact; 2005 Oct; 156(2-3):101-11. PubMed ID: 16144695
[TBL] [Abstract][Full Text] [Related]
3. Effects of conjugated linoleic acid on liver composition and fatty acid oxidation are isomer-dependent in hamster.
Macarulla MT; Fernández-Quintela A; Zabala A; Navarro V; Echevarría E; Churruca I; Rodríguez VM; Portillo MP
Nutrition; 2005 Apr; 21(4):512-9. PubMed ID: 15811773
[TBL] [Abstract][Full Text] [Related]
4. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats.
Rivera L; Morón R; Zarzuelo A; Galisteo M
Biochem Pharmacol; 2009 Mar; 77(6):1053-63. PubMed ID: 19100718
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
7. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets.
Rocha KK; Souza GA; Ebaid GX; Seiva FR; Cataneo AC; Novelli EL
Food Chem Toxicol; 2009 Jun; 47(6):1362-7. PubMed ID: 19298841
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats.
Palsamy P; Sivakumar S; Subramanian S
Chem Biol Interact; 2010 Jul; 186(2):200-10. PubMed ID: 20307516
[TBL] [Abstract][Full Text] [Related]
10. Hepatic lipid and carbohydrate metabolism in rats fed a commercial mixture of conjugated linoleic acids (Clarinol G-80).
Giudetti AM; Beynen AC; Lemmens AG; Gnoni GV; Geelen MJ
Eur J Nutr; 2005 Feb; 44(1):33-9. PubMed ID: 15309462
[TBL] [Abstract][Full Text] [Related]
11. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
12. Effect of starvation on hepatic acyl-CoA synthetase, carnitine palmitoyltransferase-I, and acetyl-CoA carboxylase mRNA levels in rats.
Ryu MH; Daily JW; Cha YS
Nutrition; 2005 Apr; 21(4):537-42. PubMed ID: 15811777
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver.
Kasdallah-Grissa A; Mornagui B; Aouani E; Hammami M; El May M; Gharbi N; Kamoun A; El-Fazaâ S
Life Sci; 2007 Feb; 80(11):1033-9. PubMed ID: 17258234
[TBL] [Abstract][Full Text] [Related]
15. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
16. A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance.
Zheng H; Li S; Ma L; Cheng L; Deng C; Chen Z; Xie C; Xiang M; Jiang W; Chen L
Eur J Pharmacol; 2011 Jun; 659(2-3):244-51. PubMed ID: 21463618
[TBL] [Abstract][Full Text] [Related]
17. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
Takahashi N; Qi Y; Patel HR; Ahima RS
J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
[TBL] [Abstract][Full Text] [Related]
18. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
Lee ES; Shin MO; Yoon S; Moon JO
Arch Pharm Res; 2010 Jun; 33(6):925-32. PubMed ID: 20607498
[TBL] [Abstract][Full Text] [Related]
20. Green tea extract attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidant defenses in ob/ob mice.
Park HJ; DiNatale DA; Chung MY; Park YK; Lee JY; Koo SI; O'Connor M; Manautou JE; Bruno RS
J Nutr Biochem; 2011 Apr; 22(4):393-400. PubMed ID: 20655714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
